Relativity Acquisition Corp. Announces the Public Filing of a Registration Statement on Form F-4 for Instinct Bio Technical Company Inc.
Relativity Acquisition Corp announced that Instinct Bio Technical Company has publicly filed a Form F-4 registration statement with the SEC on September 8, 2025. This filing relates to the previously announced business combination between Relativity and Instinct Brothers Co, a Tokyo-based stem cell skincare and wellness company.
The Form F-4 includes a preliminary proxy statement/prospectus detailing the proposed business combination and related shareholder voting information. Following the completion of the merger, the combined entity will operate as Instinct Bio Technical Company Holdings and plans to list on the NASDAQ under the ticker symbol 'BIOT'.
Relativity Acquisition Corp ha annunciato che Instinct Bio Technical Company ha presentato pubblicamente una dichiarazione di registrazione Form F-4 alla SEC l'8 settembre 2025. Questa documentazione riguarda l'accordo commerciale precedentemente annunciato tra Relativity e Instinct Brothers Co, una società con sede a Tokyo specializzata in skincare a base di cellule staminali e benessere.
Il Form F-4 include una bozza di proxy statement/prospectus che dettaglia la fusione proposta e le relative informazioni di voto degli azionisti. Dopo la chiusura della fusione, l'entità combinata opererà come Instinct Bio Technical Company Holdings e prevede di essere quotata sul NASDAQ con il simbolo di ticker 'BIOT'.
Relativity Acquisition Corp anunció que Instinct Bio Technical Company ha presentado públicamente una declaración de registro Form F-4 ante la SEC el 8 de septiembre de 2025. Esta presentación está relacionada con la combinación de negocios entre Relativity y Instinct Brothers Co, una empresa con sede en Tokio dedicada a skincare y bienestar con células madre.
El Form F-4 incluye una proxy statement/prospectus preliminar que detalla la fusión propuesta y la información de votación de los accionistas. Tras la finalización de la fusión, la entidad combinada operará como Instinct Bio Technical Company Holdings y planea cotizar en NASDAQ bajo el símbolo de ticker 'BIOT'.
Relativity Acquisition Corp가 Instinct Bio Technical Company가 2025년 9월 8일 SEC에 Form F-4 등록신고서를 공개적으로 제출했다고 발표했습니다. 이 제출은 Relativity와 Instinct Brothers Co 간에 앞서 발표된 사업 결합과 관련이 있으며, 도쿄에 본사를 둔 줄기세포 스킨케어 및 웰빙 회사입니다.
Form F-4에는 제안된 사업 결합 및 주주 의결 정보가 자세히 담긴 예비 의결권진술서/공개설명서가 포함되어 있습니다. 합병이 완료되면 합병 법인은 Instinct Bio Technical Company Holdings로 운영되며 NASDAQ에 BIOT 티커로 상장할 계획입니다.
Relativity Acquisition Corp a annoncé que Instinct Bio Technical Company a publié publiquement un formulaire d'enregistrement Form F-4 auprès de la SEC le 8 septembre 2025. Cette soumission concerne la combinaison d'entreprises précédemment annoncée entre Relativity et Instinct Brothers Co, une société basée à Tokyo spécialisée dans les soins de la peau et le bien-être à base de cellules souches.
Le Form F-4 comprend une déclaration de procuration/prospectus préliminaire détaillant la fusion proposée et les informations de vote des actionnaires associées. Après la finalisation de la fusion, l'entité fusionnée opérera sous le nom de Instinct Bio Technical Company Holdings et prévoit d'être cotée sur le NASDAQ sous le symbole de ticker 'BIOT'.
Relativity Acquisition Corp hat bekannt gegeben, dass Instinct Bio Technical Company am 8. September 2025 öffentlich eine Form F-4 Registrierungsunterlage bei der SEC eingereicht hat. Diese Einreichung steht im Zusammenhang mit der zuvor angekündigten Unternehmenszusammenführung zwischen Relativity und Instinct Brothers Co, einem in Tokio ansässigen Unternehmen für Stammzell-Hautpflege und Wellness.
Das Form F-4 enthält eine vorläufige Proxystatement/Prospectus, die die vorgeschlagene Unternehmenszusammenführung und die damit verbundenen Informationen zur Abstimmung der Aktionäre im Detail erläutert. Nach Abschluss der Fusion wird das zusammengeschlossene Unternehmen als Instinct Bio Technical Company Holdings operieren und plant, an der NASDAQ unter dem Tickersymbol 'BIOT' gelistet zu werden.
Relativity Acquisition Corp أعلنت أن Instinct Bio Technical Company قد قدمت علناً نموذج التسجيل Form F-4 لدى هيئة الأوراق المالية الأميركية SEC في 8 سبتمبر 2025. تتعلق هذه الإيداع بالاندماج التجاري الذي أُعلن عنه سابقاً بين Relativity و Instinct Brothers Co، شركة مقرها طوكيو ومتخصصة في العناية بالبشرة باستخدام الخلايا الجذعية والرفاهية.
يتضمن Form F-4 بيان تفويض/كتلة استباقي تفصيلي يشرح الاندماج المقترح ومعلومات تصويت المساهمين المرتبطة به. بعد إتمام الدمج، ستعمل الكيان المدموج كـ Instinct Bio Technical Company Holdings وتخطط للإدراج في NASDAQ تحت رمز التداول 'BIOT'.
Relativity Acquisition Corp宣布，Instinct Bio Technical Company已于2025年9月8日向美国证券交易委员会公开提交了Form F-4注册声明。此次提交与先前宣布的 Relativity 与 Instinct Brothers Co之间的商业合并有关，该公司总部位于东京，专注于干细胞护肤与健康。
Form F-4 包含初步的代理声明/招股说明书，详细说明拟议的业务合并及相关的股东投票信息。合并完成后，合并实体将以 Instinct Bio Technical Company Holdings 的名义运营，并计划在 NASDAQ 上上市，股票代码为 'BIOT'。
- Planned uplisting to NASDAQ, providing increased visibility and potential liquidity
- Strategic merger with established Japanese stem cell skincare company
- Vertical integration in the growing wellness sector
- Regulatory approval from SEC still pending
- Integration risks between US and Japanese operations
- Potential cultural and operational challenges in cross-border merger
Las Vegas, NV, Tokyo, Japan, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Relativity Acquisition Corp. (“Relativity”) today announced that on September 8, 2025, Instinct Bio Technical Company Inc. (“Instinct Bio”) publicly filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form F-4 (the “Form F-4”) in connection with Relativity’s previously announced proposed business combination (the “Business Combination”) with Instinct Brothers Co., Ltd. (“Instinct Brothers”), a vertically integrated stem cell skincare and wellness company headquartered in Tokyo, Japan. The Form F-4, which includes a preliminary proxy statement/prospectus, provides detailed information regarding the proposed Business Combination and the related shareholder vote, and is available on the SEC’s website at www.sec.gov. Upon closing the Business Combination, the combined company will operate under the name Instinct Bio Technical Company Holdings Inc. and intends to list on the NASDAQ Stock Exchange under the ticker symbol ‘BIOT’.
About Instinct Brothers
Instinct Brothers is a vertically integrated Japanese company specializing in stem cell skincare and wellness products, encompassing research and development, manufacturing, distribution, retail, and clinical applications. Founded in 2011, with its focus on stem cell skincare and wellness products beginning in 2017, Instinct Brothers is led by industry expert Tomoki Nagano, Chairman and Group Chief Executive Officer, with a vision to drive innovation in regenerative medicine. The mission of Instinct Brothers is to advance stem cell science, enhance patient outcomes, and pioneer the next generation of stem cell-based therapies.
About Relativity Acquisition Corp.
Relativity Acquisition Corp. is a blank check company sponsored by Relativity Acquisition Sponsor LLC, a Delaware limited liability company, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Additional Information and Where to Find It
In connection with the Business Combination, Relativity Holdings Inc. and Instinct Bio have filed a registration statement on Form F-4 (the “Form F-4”) with the United States Securities and Exchange Commission ( the “SEC”), which includes a preliminary prospectus with respect to its securities to be issued in connection with the Business Combination and a preliminary proxy statement with regard to Relativity’s stockholder meeting at which Relativity’s stockholders will be asked to vote on the Business Combination. Relativity’s investors, stockholders and other interested persons are advised to read the Form F-4, including the proxy statement/prospectus, any amendments thereto and any other documents filed with the SEC, because these documents will contain important information about the proposed Business Combination. After the Form F-4 has been declared effective, Relativity will mail the definitive proxy statement/prospectus to stockholders of Relativity as of a record date to be established for voting on the business combination. Relativity stockholders will also be able to obtain a copy of such documents, without charge, by directing a request to: Relativity Acquisition Corp., 3753 Howard Hughes Parkway, Suite 200 Las Vegas, Nevada 89169; e-mail: info@relativityacquisitions.com. These documents, once available, can also be obtained, without charge, at the SEC’s website www.sec.gov.
Participants in the Solicitation
Relativity and Instinct Bio and their respective directors and officers may be deemed participants in soliciting proxies of Relativity’s stockholders in connection with the proposed business combination. Security holders may obtain more detailed information regarding the names, affiliations and interests of the executive officers and directors of Relativity and Instinct Bio in the F-4 and other relevant materials filed with the SEC in connection with the Business Combination when they become available. Information concerning the interests of Relativity’s participants in the solicitation, which may, in some cases, be different from those of their stockholders generally, will be set forth in the Form F-4.
No Offer or Solicitation
This press release does not constitute an offer to sell or a solicitation of an offer to buy, or the solicitation of any vote or approval in any jurisdiction in connection with the proposed potential business combination among Relativity and Instinct Bio or any related transactions, nor shall there be any sale, issuance or transfer of securities in any jurisdiction where, or to any person to whom, such offer, solicitation or sale may be unlawful. Any offering of securities or solicitation of votes regarding the proposed transaction will be made only by means of a proxy statement/prospectus that complies with applicable rules and regulations promulgated under the Securities Act of 1933, as amended (the “Securities Act”), and Securities Exchange Act of 1934, as amended, or pursuant to an exemption from the Securities Act or in a transaction not subject to the registration requirements of the Securities Act.
Forward Looking Statements
This press release may include, and oral statements made from time to time by representatives of Relativity or Instinct Brothers may include “forward-looking statements”. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release, are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, management of Relativity and Instinct Brothers. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Relativity or Instinct Brothers, including those set forth in the Risk Factors section of the Form F-4 and prospectus filed with the SEC. Relativity and Instinct Brothers undertake no obligation to update these statements for revisions or changes after the date of this release except as required by law.
Contact Information
Instinct Bio Technical Co., Ltd.
Email: ir@instinct-biot.com
Website: https://instinct-bro.com/
Relativity Acquisition Corp.
Email: info@relativityacquisitions.com
Website: www.relativityacquisitions.com
FAQ
What is the new ticker symbol for Instinct Bio Technical Company after the merger?
When did Instinct Bio Technical Company file its F-4 registration statement with the SEC?
What type of company is Instinct Brothers Co?
What will be the name of the combined company after the Relativity Acquisition merger?
Where can investors find the Form F-4 registration statement for the Relativity-Instinct Bio merger?
